News Letter to Shareholders and Corporate Update Continue Reading Previous Sandoz announces exclusive deal to commercialize biosimilar ustekinumab, further reinforcing growing pipeline and immunology patient offeringNext Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPD Related Stories News HiBob Named Best HR Management Software in the UK for 2026 News Ionik Announces 30-Day Extension of Senior Debt Facility News NTG Clarity to Announce First Quarter Financial Results on May 27, 2026 with Earnings Call to Follow News QuantumCore Announces Changes to Board of Directors News Voghion Expands Beyond Fashion to Build a One-Stop Lifestyle Platform Across Europe News Boba Closes Private Placement for Proceeds of $325,000
